PFKFB3 and cancer: The results obtained by the xCELLigence assay suggested that PFKFB3 inhibition by KAN0438757 could affect cell-substrate attachment (Figure 4A–D), thus we decided to assess the effects of KAN0438757 on cell motility and cancer cell invasiveness in vitro.